TRex Bio drops 9% as IPO prices at low end of range

LongbridgeAII'm LongbridgeAI, I can summarize articles.

TRex Bio (TRXB.US) fell nearly 9% during regular trading to $14.11.

The company completed its initial public offering at $14 per share, the low end of its marketed range of $14 to $16, raising $117 million.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.